Sonoma Pharmaceuticals In...
2.73
0.09 (3.41%)
At close: Jan 15, 2025, 11:41 AM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04
Net Income -4.83M -5.15M -5.09M -3.95M -2.95M -11.80M -14.33M 9.27M -10.16M -8.20M 3.73M -5.43M -7.33M -7.95M -8.23M -17.66M -20.34M -19.78M -21.12M -16.53M -7.30M
Depreciation & Amortization 176.00K 125.00K 186.00K 227.00K 312.00K 453.00K 490.00K 248.00K 244.00K 253.00K 284.00K 268.00K 326.00K 395.00K 433.00K 768.00K 740.00K 672.00K 651.00K 434.00K 160.00K
Stock-Based Compensation 516.00K 669.00K 382.00K 371.00K 839.00K 1.64M 2.41M 2.15M 2.34M 1.77M 1.45M 1.60M 2.80M 2.37M 1.43M 2.26M n/a 1.58M n/a n/a n/a
Other Working Capital 2.02M -1.11M 1.42M -363.00K -492.00K 672.00K -1.19M 442.00K -427.00K -1.82M -966.00K 2.83M 232.00K 1.60M 266.00K -990.00K 2.77M -214.00K -517.00K 829.00K n/a
Other Non-Cash Items 161.00K 106.00K -2.03M 4.00K 464.00K -741.00K 90.00K -15.31M 493.00K 1.67M 863.00K 624.00K -7.10M 139.00K 394.00K 372.00K -441.00K 1.72M -87.00K 2.48M 438.00K
Deferred Income Tax -109.00K -37.00K -829.00K -1.41M -1.24M n/a 651.00K -4.27M n/a n/a -10.89M 963.00K 7.36M 155.00K 72.00K 299.00K n/a -1.58M n/a n/a n/a
Change in Working Capital 1.69M -1.86M 3.13M 1.38M -2.02M -1.27M -1.75M -257.00K -1.66M -2.18M -332.00K 3.13M -83.00K 464.00K -738.00K -2.88M 2.59M -693.00K 34.00K 81.00K 1.14M
Operating Cash Flow -2.40M -6.15M -4.25M -3.38M -4.59M -11.72M -12.44M -8.17M -8.75M -6.69M -4.89M 1.15M -4.03M -4.43M -6.64M -16.83M -17.45M -18.08M -20.52M -13.53M -5.56M
Capital Expenditures -17.00K -269.00K -137.00K -179.00K -206.00K -100.00K -187.00K -394.00K -345.00K -139.00K -504.00K -257.00K -336.00K -174.00K -141.00K -393.00K -617.00K -873.00K -475.00K -1.04M -980.00K
Acquisitions n/a n/a n/a n/a 2.70M n/a n/a 18.64M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -113.00K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a n/a 4.54M 963.00K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies 15.00K 11.00K 38.00K 567.00K 1.15M -31.00K -14.00K -21.00K -2.00K 51.00K 59.00K -113.00K -24.00K 10.00K -43.00K -31.00K n/a -4.00K -1.11M -76.00K -30.00K
Investing Cash Flow -2.00K -258.00K -99.00K 388.00K 3.64M -131.00K -201.00K 18.22M 4.19M 875.00K -445.00K -370.00K -360.00K -164.00K -184.00K -424.00K -617.00K -877.00K -1.58M -1.12M -1.01M
Debt Repayment -481.00K -120.00K -467.00K 1.02M -347.00K -478.00K -280.00K -130.00K -119.00K -176.00K -1.61M -2.08M 1.34M 2.59M -294.00K -2.14M -4.11M 5.31M -727.00K 500.00K n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 6.84M
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 373.00K 2.61M 7.86M n/a 1.38M n/a 52.00K 98.00K 14.00K n/a 1.37M 891.00K 219.00K n/a n/a n/a n/a 401.00K -478.00K n/a 7.27M
Financial Cash Flow 1.68M 2.49M 7.40M 3.31M 1.03M 5.49M 5.24M -32.00K 6.04M 6.61M 2.94M 3.75M 3.45M 2.68M 11.08M 376.00K 17.83M 30.57M 26.12M 17.20M 7.27M
Net Cash Flow -692.00K -3.58M 3.18M 529.00K 2.00K -6.38M -7.39M 9.99M 1.33M 656.00K -2.42M 4.55M -1.02M -1.89M 4.34M -16.90M -227.00K 11.60M 4.16M 2.42M 690.00K
Free Cash Flow -2.42M -6.42M -4.38M -3.56M -4.80M -11.82M -12.63M -8.56M -9.09M -6.83M -5.39M 893.00K -4.37M -4.60M -6.78M -17.23M -18.06M -18.95M -21.00M -14.57M -6.54M